Skip to main content
Clinical Trials/NCT06131853
NCT06131853CompletedNot Applicable

Physical Activity, Fear of Falling, Fatigue and Functionality in Prostate Cancer

Selcuk University2 sites in 1 country50 target enrollmentStarted: November 9, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
2
Primary Endpoint
International Physical Activity Survey short form

Study Overview

Brief Summary

This study aimed to investigate the effects of prostate cancer on patients' physical activity, kinesiophobia, fatigue and functionality.

This research is a prospective study to be conducted on volunteer individuals between the ages of 40-75. People diagnosed with prostate cancer (study group) and healthy adults who have not been diagnosed with prostate cancer before (control group) will be included in the study. The demographic characteristics, physical activity levels and quality of life of all individuals participating in the study will be evaluated with an online form. In demographic data, physical, sociodemographic data such as age (years), height (cm), body weight (kg), body mass index (kg/m2) and disease-specific information will be recorded. Physical activity level will be measured with the International Physical Activity Survey short form (UFAA), fatigue with the Functional Evaluation of Chronic Disease Treatment-Fatigue Questionnaire, fear of movement with the Causes of Fear of Movement Questionnaire, and quality of life with the Functional Evaluation of Cancer Treatment-Prostate Version questionnaire (KHTFD-Y).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
40 Years to 75 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • (for prostate cancer-study group)
  • Being between the ages of 40-75
  • Want to participate in the study
  • Being able to read and write
  • Being diagnosed with prostate cancer by a specialist physician,
  • Being able to provide their mobility independently,
  • (for healthy controls - control group)
  • Being between the ages of 40-75
  • Not having any previous cancer history and not having undergone cancer surgery
  • Volunteering to participate in the study

Exclusion Criteria

  • Those with a previously known or accompanying diagnosis of dementia
  • Not wanting to participate in the study
  • The individual has a disease that may prevent him or her from understanding and completing the survey.
  • Illiterates
  • Those who do not want to participate in the research voluntarily
  • Having active metastasis
  • Having undergone chemotherapy and radiotherapy in the last 6 months

Outcomes

Primary Outcomes

International Physical Activity Survey short form

Time Frame: 10 minutes

The short form consists of 7 questions. The form provides information about the frequency and time spent in walking, moderate physical activity, and vigorous physical activity.

Functional Assessment of Fatigue Chronic Disease Treatment-Fatigue Questionnaire

Time Frame: 10 minutes

It consists of 13 questions that evaluate the level of fatigue that occurred during daily activities in the last 7 days. Scoring varies between 0-52. High scores indicate less fatigue.

Functional Evaluation of Cancer Treatment-Prostate Version questionnaire

Time Frame: 10 minutes

It consists of 13 questions that evaluate the level of fatigue that occurred during daily activities in the last 7 days. Scoring varies between 0-52. High scores indicate less fatigue.

Reasons for Fear of Movement Questionnaire

Time Frame: 10 minutes

It allows the causes of kinesiophobia to be identified and both biological and psychological causes to be determined separately. The average of the scores obtained from the biological and physiological subscales gives the total score from the survey. A 5-point Likert scoring (1 = Totally disagree, 5 = Completely agree) is used in the scale. An individual's high score from the survey indicates that he/she has more fear of movement.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Emine Cihan

Asst Prof Dr

Selcuk University

Study Sites (2)

Loading locations...

Similar Trials

Kinesiophobia in Prostate Cancer | Clinical Trial